Glow
Dermatological Research Blend - GHK-Cu, BPC-157 & TB-500 blend for skin-research protocols.
Glow is a co-formulated blend combining a copper peptide with two repair peptides, prepared for dermatological and regenerative research applications.
Blends are characterized component by component rather than as one entity, so the lot certificate lists each peptide's identity and content separately - the reason a blend shows two or three figures where a single peptide shows one. Work using this combination generally examines the copper-delivery and matrix-repair routes together rather than isolating either.
Glow specifications
- Molecular formula
- Co-formulated blend
- Sequence
- GHK-Cu + BPC-157 + TB-500
- Residues
- GHK-Cu + BPC-157 + TB-500
- Presentation
- Blue lyophilized powder
- Documented purity
- 99.91% by HPLC
- Available sizes
- 70mg ($80)
- Archived COA lots
- 7
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Skin matrix study - Investigated for combined collagen-signaling and repair activity in skin models.
Reported mechanisms in the literature
- Skin-matrix study - Combines a copper peptide with two repair peptides for study of collagen-signaling and repair activity together in skin-research models. (Combination research)
- Regenerative pathways - Investigated for overlap between matrix remodeling and tissue-repair signaling in dermatological and regenerative research. (Preclinical literature)
What Glow is researched for
- Skin renewal - Studied for combined collagen-signaling and tissue-repair activity in skin-research models. (Combination research)
- Matrix remodeling - Investigated for overlapping matrix and repair pathways across its component peptides. (Preclinical literature)
Glow certificates of analysis on file
Every lot below was tested by an independent laboratory and the full report is published as a PDF. Purity is shown exactly as the report states it. The same records are searchable in the COA library and can be checked on the lot verification page.
| Lot | Tested | Size | Laboratory | HPLC purity | Identity | Certificate |
|---|---|---|---|---|---|---|
| GLOW-101926-70 | 22 Oct 2026 | 70mg | ILS Laboratories | 99.90% | Confirmed (HPLC retention time) | COA PDF |
| H2PHZW | 16 Oct 2026 | 50mg | Freedom Diagnostics | 99.92% | Confirmed (LC-MS/MS) | COA PDF |
| 3NFBB0 | 15 Sep 2026 | 70mg | Freedom Diagnostics | 99.84% | Confirmed (LC-MS/MS) | COA PDF |
| FD-2606030675 | 7 Jun 2026 | 70mg | Freedom Diagnostics | 99.68% | Confirmed (LC-MS/MS) | COA PDF |
| FD-2605270309 | 27 May 2026 | 70mg | Freedom Diagnostics | 99.80% | Confirmed (LC-MS/MS) | COA PDF |
| FD-2602180089 | 18 Feb 2026 | 50mg | Freedom Diagnostics | 99.91% | Confirmed (LC-MS/MS) | COA PDF |
| FD-2512290014 | 29 Dec 2025 | 10mg | Freedom Diagnostics | 99.54% | Confirmed (LC-MS/MS) | COA PDF |
Published literature on Glow
The mechanisms above trace to peer-reviewed studies indexed on PubMed. These are independent third-party publications, not Aspect Peptides claims. Browse indexed research on PubMed.
Glow frequently asked questions
What is Glow?
A co-formulated blend of GHK-Cu with BPC-157 and TB-500, prepared for dermatological and regenerative research.
Is Glow approved for cosmetic or human use?
No. It is a laboratory research material only; it is not a cosmetic, drug, or supplement.
How is it documented?
Each lot ships with its Certificate of Analysis.
Documented to 99.91% purity by HPLC · third-party COA every lot · from $80 · For laboratory research use only.
Related Regenerative & Repair compounds
- BPC-157 - Synthetic pentadecapeptide studied for VEGF and growth-factor receptor signaling.
- TB-500 - Thymosin β-4 fragment studied for actin regulation and tissue repair.
- BPC-157 / TB-500 - Co-formulated repair-research blend in a single vial.
- BPC-157 / TB-500 / KPV - BPC-157, TB-500 and KPV co-formulated in a single vial.
- GHK-Cu - Copper tripeptide studied in skin-remodeling research.
- KPV - α-MSH C-terminal fragment studied for inflammatory signaling.